论文部分内容阅读
检测65例子宫颈癌前病变和癌变患者与102例正常对照组的SF、β-hCG、CEA、及AFP水平。结果实验组SF、β-hCG及CEA均显著高于对照组,并随子宫颈癌临床期别增高而升高;AFP在两组之间差异无显著性。SF、β-hCG及CEA诊断子宫颈癌的可用度分别为53.4％、55.7％、53.5％,三项指标联合应用的可用度可提高到70.0％。但无助于早期癌肿诊断。
The levels of SF, β-hCG, CEA, and AFP in 65 cases of cervical precancerous lesions and cancerous patients and 102 normal controls were examined. Results The levels of SF, β-hCG and CEA in the experimental group were significantly higher than those in the control group and increased with the increase of the clinical stage of cervical cancer. There was no significant difference in AFP between the two groups. The availability of SF, β-hCG, and CEA in the diagnosis of cervical cancer was 53.4%, 55.7%, and 53.5%, respectively, and the availability of the combined use of the three indicators could be increased to 70.0%. However, it does not contribute to the diagnosis of early cancer.